Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Human-T-or-B-cell-lines-and-a-process-for-producing-immunologically-active-substances-using-the-same

 Herbicidal cinnamic ester uracils
OF THE INVENTION The compounds of formula (I) may be prepared according to the following scheme: ##...


 Pyridinesulfonamide derivatives and herbicides
We claim: 1. A pyridinesulfonamide derivative of the formula (I) and a salt thereof: wherein R.sup.1...


 Dihydroxyphenylethylaminoalkyl theophyllines
What is claimed is: 1. A compound corresponding to the general formula ##STR6## in which T is the ...


 Fungicidal agents LL-15G256.gamma.,.delta., and .epsilon. produced by LL-15G256 (Hypoxylon oceanicum)
The invention provides to the art novel antifungal compounds of Formula I and II: ##STR2## ##STR3## ...


 Continuous production of ethanol by use of flocculent zymomonas mobilis
OF PREFERRED APPARATUS AND PROCESS EMBODIMENTS OF THE INVENTION The effectiveness of strains of Z...


 Bio-protein feed manufacturing method
What is claimed is: 1. A method for manufacturing a bioprotein animal feed supplement comprising: ...


 Microbiological process for controlling the productivity of cultivated plants
We claim: 1. A microbiological process for controlling the productivity of cultivated plants, which ...


 Soil conditioners
OF THE PREFERRED EMBODIMENTS The soil conditioner of the present invention comprises 4 to 4.75 ...


 Method for the manufacture of fodder and/or soil improving agents from waste material
OF THE INVENTION The method according to the invention, basically, resides in that the ...


 Process of bio-conversion of industrial or agricultural cellulose containing organic wastes into a proteinaceous nutrition product
According to one aspect of the present invention there is provided a process of conversion of low ...


 Human T or B cell lines and a process for producing immunologically active substances using the same

Details
Inventors: Takano, Satoshi; Morioka, Hajimu; Shibai, Hiroshiro; Onodera, Kazukiyo;
Assignee: Ajinomoto Co., Inc. (Tokyo, JP)
Primary Examiner: Weimar; Elizabeth
Assistant Examiner:
Attorney, Agent or Firm: Oblon, Fisher, Spivak, McClelland & Maier

This invention relates to a human T or B cell line carrying at least one Ela human adenovirus 12-type gene or fragment thereof; said cell line being capable of spontaneously producing an immmunologically active substance. This invention also relates to a process for producing an immunologically active substance comprising culturing a human B- or T- cell line carrying at least one human Ela adenovirus 12-type gene or fragment thereof in a culture medium capable of supporting growth thereof for a period of time effective to attain a spontaneous production of the substance thereof.

DETAILED DESCRIPTION What is claimed as new and desired to be secured by letters patent of the United States is: 1.
A human T or B cell line selected from the group consisting of Jurkat cells and Namalwa cells carrying at least one E1a Human adenovirus 12-type gene; said cell line being capable of constitutively producing an immunologically active substance selected from the group consisting of .
alpha.
-, .
beta.
- or .
gamma.
-interferon, interleukin-2, interleukin-1, B cell growth factor and CSF.
2.
The cell line of claim 1, which is Jurkat-MTE-31-12.
3.
The cell line of claim 1, which is Jurkat-MTE-23.
4.
The cell line of claim 1, which is a Namalwa cell.
5.
A process for producing an immunologically active substance comprising culturing a human B- or T-cell line selected from the group consisting of Jurkat cells and Namalwa cells carrying at least one human E1a adenovirus 12-type gene, in a culture medium capable of supporting growth thereof for a period of time effective to attain constitutive production of the substance thereof, wherein said substance is selected from the group consisting of .
alpha.
-, .
beta.
- or .
gamma.
-interferon, interleukin-2, interleukin-1, B cell growth factor and CSF.
6.
A process according to claim 5, wherein said cell line is selected from the group consisting of Jurkat-MTE-23 and Jurkat-MTE-31-12.




Description:
BACKGROUND OF THE INVENTION 1.
Field of the Invention The present invention relates to improved human T or B cell lines and a process for producing immunologically active substances using the same.
2.
Discussion of Background It has heretofore been known that human T and B cell lines are stimulated by immunologically active substance inducers such as lectin, etc.
to produce soluble, immunologically active substances such as .
alpha.
-, .
beta.
- or .
gamma.
-interferons, interleukin-2, interleukin-1, B cell growth factor, CSF, etc.
In most cases, however, these human T and B cell lines will not produce immunologically active substances unless they are stimulated by immunologically active substance inducers such as phorbol ester, lectin, etc



Related patents
  Nif promoter of fast-growing rhizobium japonicum
OF THE INVENTION The taxon Rhizobium japonicum can be split into two groups, fast-growing rhizobia and slow-growing rhizobia or "bradyrhizobia" (Jordan, D. C. (1982) I...
  Macrolide compounds, their preparation and their use
OF THE PRESENT INVENTION In the compounds of formula (I), where R.sup.2 represents a group of the formula --C(CH.sub.3).dbd.CHR.sup.5, the group R.sup.2 is a 1-methyl-1-...
  Hyperexpression of bioelastic polypeptides
Accordingly, it is an object of the present invention to provide methods and compositions for synthesizing elastomeric materials in large quantities. It is a further ...
  Method of regulating expression of a foreign gene by controlling culture temperature and a process of producing a foreign gene product thereby
In view of the above-mentioned problems and in quest of establishing more effective means to produce foreign gene products, the present inventors have made several ...
  Preparation of erythorbic acid and ascorbis acid 6-fatty acid esters
OF THE INVENTION The process of the present invention results in esterification of erythorbic and ascorbic acids specifically at the C-6 primary alcohol. Such ...
  Tolan-type nematic liquid crystalline compounds
What is claimed is: 1. A compound of the general formula ##STR184## wherein R represents a linear alkyl group having 1 to 10 carbon atoms, R' represents a halogen atom ...
  Process for extracting lignin from lignocellulosic material using an aqueous organic solvent and an acid neutralizing agent
OF THE PREFERRED EMBODIMENTS With reference to FIG. 1, the results shown therein were in relation to a series of cooks in which the mixture of wood material and liquor ...
  Finely divided suspension of cellulosic material
An object of this invention is to provide a suspension containing finely divided particles of a cellulosic material in high concentrations. Another object of this ...
  Herbicidal heterocyclic compounds
OF THE INVENTION The present invention is concerned with heterocyclic compounds. namely C.sub.1-4 -alkyl. C.sub.2-4 -alkenyl and C.sub.3 or .sub.4 -alkynyl enol ethers ...
  3-aryldihydrouracils
The present invention is directed to a class of compounds having the structural formula ##STR4## where R.sup.1 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.3 -C.sub.6 ...

0.074

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved